Cargando…
Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
The extracellular matrix (ECM) is the complex network of proteins that surrounds cells in multicellular organisms. Due to its diverse nature and composition, the ECM has a multifaceted role in both normal tissue homeostasis and pathophysiology. It provides structural support, segregates tissues from...
Autores principales: | Roy, David M, Walsh, Logan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090043/ https://www.ncbi.nlm.nih.gov/pubmed/25114586 http://dx.doi.org/10.2147/BCTT.S46020 |
Ejemplares similares
-
Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy
por: Srikanth, Sandhya, et al.
Publicado: (2016) -
Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2015) -
Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment
por: Huang, Mei-Ling, et al.
Publicado: (2022) -
Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer
por: Cormio, Antonella, et al.
Publicado: (2021) -
Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)